Area of research
Ophthalmology · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Macular degeneration and Ranibizumab, with related work in Visual prosthesis, Diabetic retinopathy, Aflibercept. Notable publications include 'Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase...', 'Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial', and 'TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES'.
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema
Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy
SUPRACHOROIDAL SPACE INJECTION TECHNIQUE
Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study
KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER – survey)
Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment
Artificial Intelligence Detection of Diabetic Retinopathy
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Management of Fluid in Neovascular Age-related Macular Degeneration: To Mop it, to Dab it, or to Leave it?
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Evidence-Based Guidelines for Management of Diabetic Macular Edema
Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System
Macula Society Collaborative Retrospective Study of Ocriplasmin for Symptomatic Vitreomacular Adhesion
Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES
Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies